640 related articles for article (PubMed ID: 28581505)
21. The genome editing revolution: A CRISPR-Cas TALE off-target story.
Stella S; Montoya G
Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
[TBL] [Abstract][Full Text] [Related]
22. Methods for characterizing, applying, and teaching CRISPR-Cas systems.
Beisel CL
Methods; 2020 Feb; 172():1-2. PubMed ID: 31954772
[No Abstract] [Full Text] [Related]
23. Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems.
Heussler GE; O'Toole GA
J Bacteriol; 2016 May; 198(10):1481-6. PubMed ID: 26929301
[TBL] [Abstract][Full Text] [Related]
24. The Anti-CRISPR Story: A Battle for Survival.
Maxwell KL
Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
[TBL] [Abstract][Full Text] [Related]
25. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.
Wright AV; Nuñez JK; Doudna JA
Cell; 2016 Jan; 164(1-2):29-44. PubMed ID: 26771484
[TBL] [Abstract][Full Text] [Related]
26. CRISPR technologies for bacterial systems: Current achievements and future directions.
Choi KR; Lee SY
Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
[TBL] [Abstract][Full Text] [Related]
27. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
28. The CRISPR-Antibiotic Resistance Connection.
Gilmore MS
CRISPR J; 2019 Aug; 2():199-200. PubMed ID: 31436505
[No Abstract] [Full Text] [Related]
29. Overview of CRISPR-Cas9 Biology.
Ratner HK; Sampson TR; Weiss DS
Cold Spring Harb Protoc; 2016 Dec; 2016(12):pdb.top088849. PubMed ID: 27934695
[TBL] [Abstract][Full Text] [Related]
30. Diversity of CRISPR-Cas immune systems and molecular machines.
Barrangou R
Genome Biol; 2015 Nov; 16():247. PubMed ID: 26549499
[TBL] [Abstract][Full Text] [Related]
31. Prime Time for Genome Editing?
Urnov FD
N Engl J Med; 2020 Jan; 382(5):481-484. PubMed ID: 31995698
[No Abstract] [Full Text] [Related]
32. CrisprGE: a central hub of CRISPR/Cas-based genome editing.
Kaur K; Tandon H; Gupta AK; Kumar M
Database (Oxford); 2015; 2015():bav055. PubMed ID: 26120138
[TBL] [Abstract][Full Text] [Related]
33. The plant engineer.
Pennisi E
Science; 2016 Sep; 353(6305):1220-4. PubMed ID: 27634519
[No Abstract] [Full Text] [Related]
34. CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens.
Shabbir MAB; Shabbir MZ; Wu Q; Mahmood S; Sajid A; Maan MK; Ahmed S; Naveed U; Hao H; Yuan Z
Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):21. PubMed ID: 31277669
[TBL] [Abstract][Full Text] [Related]
35. The roles of CRISPR-Cas systems in adaptive immunity and beyond.
Barrangou R
Curr Opin Immunol; 2015 Feb; 32():36-41. PubMed ID: 25574773
[TBL] [Abstract][Full Text] [Related]
36. The Heroes of CRISPR.
Lander ES
Cell; 2016 Jan; 164(1-2):18-28. PubMed ID: 26771483
[TBL] [Abstract][Full Text] [Related]
37. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas Systems towards Next-Generation Biosensing.
Li Y; Li S; Wang J; Liu G
Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
[TBL] [Abstract][Full Text] [Related]
39. Profile of Dana Carroll.
Viegas J
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9331-9333. PubMed ID: 30201719
[No Abstract] [Full Text] [Related]
40. Current and future prospects for CRISPR-based tools in bacteria.
Luo ML; Leenay RT; Beisel CL
Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
